md: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	-38,856	-10,294
Net increase in cash and cash equivalents	110,119	-5,208
Cash and cash equivalents at beginning of period	229,940	-
Cash and cash equivalents at end of period	340,059	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by financing activities	-38,856	-10,294
Net increase in cash and cash equivalents	110,119	-5,208
Cash and cash equivalents at beginning of period	229,940	-
Cash and cash equivalents at end of period	340,059	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Pediatrix Medical Group, Inc. (MD)